Pentadeca Arginate

Very early research

The research is at the earliest stage – mostly cells in a lab dish. It is far too early to say much.

Also called PDA / PDA-157 / Pentadecapeptide arginate

A newer variant of BPC-157 with a changed salt form. Very little published research exists on it specifically.

Can a doctor prescribe this?

No. Pharmacies are not on record as being allowed to make this into a medicine.

The FDA has not approved this as a medicine.

Not approved and not on the compounding list. It was not part of the July 2026 review.

Official status: Not on the 503A bulks list. Checked 2026-08-04.

Doses used in research

Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.

No dosing information has been published in the research indexed here.

No studies indexed yet.